Dr. Howard Jacobs is a highly respected physician licensed in Ontario with over a decade of experience in evaluating and treating chronic head, neck, facial, and spinal pain. A Diplomat of both the American and Canadian Academies of Pain Management, he has held prestigious leadership roles, including Past Chair of the Section of Pain Physicians of the Ontario Medical Association and Past President of the Canadian Academy of Pain Management. Dr. Jacobs has also served as an expert witness in chronic pain cases for Ontario's Financial Insurance Services Commission and the court system. He is a renowned lecturer on chronic pain management, both in Ontario and internationally.

James Henry is a neurophysiologist who has worked throughout his career to understand the underlying mechanisms of acute and chronic pain. In January 2005, he joined McMaster as the inaugural scientific director of the Michael G. DeGroote Institute for Pain Research and Care, and as a professor in the Departments of Psychiatry and Behavioural Neurosciences, and Anesthesia. He also holds a newly endowed chair in central pain.

Henry founded the Canadian Consortium on Pain Mechanisms, Diagnosis, and Management, which is comprised of 40 top pain researchers in a multidisciplinary, all-Canadian think-tank to promote pain research, improve pain management, and disseminate information on pain to patients, practitioners, and policymakers.

Dr. Jennifer Woodell-May, PhD, is a leading expert in orthopedic biologics and a Research Director at Zimmer Biomet. She earned her PhD and MS in Bioengineering from Clemson University and a BS in Physics from Furman University. Since 2001, she has worked in R&D roles at Biomet, Inc., and later Zimmer Biomet, where she manages research for marketed therapies and spearheads pre-clinical, clinical, and regulatory efforts for new technologies.

Passionate about translating scientific innovation from bench to bedside, Dr. Woodell-May values creating therapies that improve patients' quality of life. 

Dr. Drew Taylor is a visionary in regenerative medicine, committed to making advanced, personalized healthcare solutions widely accessible. As the co-founder of Acorn Biolabs in 2017, he has spearheaded innovation in stem cell banking and regenerative health. Before Acorn, Dr. Taylor served as Chief Science Officer at Epic Capital Management, engaging with the biotech start-up ecosystem, and contributed to groundbreaking research with the Bioengineering of Skeletal Tissues Team at Mount Sinai Hospital.

Dr. Taylor earned his bachelor’s and master’s degrees in Molecular, Cellular, and Developmental Biology from the University of Michigan and a PhD in Biomedical Engineering from the University of Toronto. He also pursued a successful career as a professional pitcher for the Toronto Blue Jays and the Philadelphia Phillies, blending the discipline of sports with the innovation of science.